Medical Tourism:
Myths & Realities

Lower costs come from lower labour rates, less malpractice coverage and government support — but do not mean cheap equipment.

Many surgeons practising in places like India, Thailand and Turkey have trained at top institutes in the US, Europe and Canada. Moreover, due to larger numbers of patients, they typically have performed more complicated surgeries than their Western counterparts.

Most leading hospitals are JCI accredited (Joint Commission International), have robotic surgical suites and diagnostic equipment that rivals what you would find in hospitals across Europe or America.

You can have your surgery done in a nice hotel, but you are NOT able to do any type of touring when post-op. Your body cannot handle it due to the increased risk of developing infection.

Many top hospitals operate mainly in English; many have staff that act as international patient coordinators, assisting patients 24 hours per day, 7 days a week — including arranging travel, appointments and interpreting.

By 2026, telemedicine is standard in medical tourism, with most packages including surgeon communication for six months post-op. Patients must establish this virtual connection before returning home to ensure continuity of care. Despite this, the greatest risk remains post-travel complications, as local doctors are often hesitant to treat foreign surgeries due to professional, clinical, and legal liability concerns.

This is the major hidden truth. When malpractice happens outside of the country, patients and their by-standers typically cannot take legal action against that doctor in their home country. Navigating another country's legal system is often prohibitively expensive and may not produce the expected results.

Every region in the world has its own types of bacteria. Patients could very well be exposed to bacteria that are resistant to common antibiotics, and local doctors may not have the experience to treat them effectively.

Although all accredited facilities must follow rigorous screening, many developing countries still have a higher risk of problems with blood transfusion supplies due to safety and availability challenges during emergencies.